CMC biosafety testing refers to ensuring the biosafety of raw materials, intermediates and final products of drugs through a series of rigorous chemical, production and control tests during the drug development and production process. These tests cover the entire process from the purchase of raw materials to the delivery of finished products, ensuring the safety of drugs for patients and the environment.
The global CMC Biosafety Testing market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.
North American market for CMC Biosafety Testing is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for CMC Biosafety Testing is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for CMC Biosafety Testing in Pharmaceutical and Biotechnology Companies is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of CMC Biosafety Testing include WuXi Biologics, Wuhan Canvest Biotechnology, Centre Testing International (CTI), Suzhou Liangchen Biotechnology, JADE Biomedical, Standard Testing Group, Sino Tech World Biologicals, Q2 Solutions, Merck, Charles River Laboratories, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for CMC Biosafety Testing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding CMC Biosafety Testing.
The CMC Biosafety Testing market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global CMC Biosafety Testing market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the CMC Biosafety Testing companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
麻豆原创 Segmentation
By Company
WuXi Biologics
Wuhan Canvest Biotechnology
Centre Testing International (CTI)
Suzhou Liangchen Biotechnology
JADE Biomedical
Standard Testing Group
Sino Tech World Biologicals
Q2 Solutions
Merck
Charles River Laboratories
Sartorius
Eurofins Scientific
CAS Testing Technical Services
SGS
Samsung Biologics
NTEK
Texcell
Sino Biological
Miracle Points
Suzhou Cefety Bioscience
Zhejiang Hengyu Biological
Segment by Type
Raw Materials
Viral Banks
Cell Banks
Others
Segment by Application
Pharmaceutical and Biotechnology Companies
CROs and CDMOs
Academic and Research Institutions
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of CMC Biosafety Testing company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Report Overview
1.1 Study Scope
1.2 麻豆原创 Analysis by Type
1.2.1 Global CMC Biosafety Testing 麻豆原创 Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Raw Materials
1.2.3 Viral Banks
1.2.4 Cell Banks
1.2.5 Others
1.3 麻豆原创 by Application
1.3.1 Global CMC Biosafety Testing 麻豆原创 Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Pharmaceutical and Biotechnology Companies
1.3.3 CROs and CDMOs
1.3.4 Academic and Research Institutions
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global CMC Biosafety Testing 麻豆原创 Perspective (2019-2030)
2.2 Global CMC Biosafety Testing Growth Trends by Region
2.2.1 Global CMC Biosafety Testing 麻豆原创 Size by Region: 2019 VS 2023 VS 2030
2.2.2 CMC Biosafety Testing Historic 麻豆原创 Size by Region (2019-2024)
2.2.3 CMC Biosafety Testing Forecasted 麻豆原创 Size by Region (2025-2030)
2.3 CMC Biosafety Testing 麻豆原创 Dynamics
2.3.1 CMC Biosafety Testing Industry Trends
2.3.2 CMC Biosafety Testing 麻豆原创 Drivers
2.3.3 CMC Biosafety Testing 麻豆原创 Challenges
2.3.4 CMC Biosafety Testing 麻豆原创 Restraints
3 Competition Landscape by Key Players
3.1 Global Top CMC Biosafety Testing Players by Revenue
3.1.1 Global Top CMC Biosafety Testing Players by Revenue (2019-2024)
3.1.2 Global CMC Biosafety Testing Revenue 麻豆原创 Share by Players (2019-2024)
3.2 Global CMC Biosafety Testing 麻豆原创 Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by CMC Biosafety Testing Revenue
3.4 Global CMC Biosafety Testing 麻豆原创 Concentration Ratio
3.4.1 Global CMC Biosafety Testing 麻豆原创 Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by CMC Biosafety Testing Revenue in 2023
3.5 Global Key Players of CMC Biosafety Testing Head office and Area Served
3.6 Global Key Players of CMC Biosafety Testing, Product and Application
3.7 Global Key Players of CMC Biosafety Testing, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 CMC Biosafety Testing Breakdown Data by Type
4.1 Global CMC Biosafety Testing Historic 麻豆原创 Size by Type (2019-2024)
4.2 Global CMC Biosafety Testing Forecasted 麻豆原创 Size by Type (2025-2030)
5 CMC Biosafety Testing Breakdown Data by Application
5.1 Global CMC Biosafety Testing Historic 麻豆原创 Size by Application (2019-2024)
5.2 Global CMC Biosafety Testing Forecasted 麻豆原创 Size by Application (2025-2030)
6 North America
6.1 North America CMC Biosafety Testing 麻豆原创 Size (2019-2030)
6.2 North America CMC Biosafety Testing 麻豆原创 Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America CMC Biosafety Testing 麻豆原创 Size by Country (2019-2024)
6.4 North America CMC Biosafety Testing 麻豆原创 Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe CMC Biosafety Testing 麻豆原创 Size (2019-2030)
7.2 Europe CMC Biosafety Testing 麻豆原创 Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe CMC Biosafety Testing 麻豆原创 Size by Country (2019-2024)
7.4 Europe CMC Biosafety Testing 麻豆原创 Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific CMC Biosafety Testing 麻豆原创 Size (2019-2030)
8.2 Asia-Pacific CMC Biosafety Testing 麻豆原创 Growth Rate by Country: 2019 VS 2023 VS 2030
8.3 Asia-Pacific CMC Biosafety Testing 麻豆原创 Size by Region (2019-2024)
8.4 Asia-Pacific CMC Biosafety Testing 麻豆原创 Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America CMC Biosafety Testing 麻豆原创 Size (2019-2030)
9.2 Latin America CMC Biosafety Testing 麻豆原创 Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America CMC Biosafety Testing 麻豆原创 Size by Country (2019-2024)
9.4 Latin America CMC Biosafety Testing 麻豆原创 Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa CMC Biosafety Testing 麻豆原创 Size (2019-2030)
10.2 Middle East & Africa CMC Biosafety Testing 麻豆原创 Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa CMC Biosafety Testing 麻豆原创 Size by Country (2019-2024)
10.4 Middle East & Africa CMC Biosafety Testing 麻豆原创 Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 WuXi Biologics
11.1.1 WuXi Biologics Company Details
11.1.2 WuXi Biologics Business Overview
11.1.3 WuXi Biologics CMC Biosafety Testing Introduction
11.1.4 WuXi Biologics Revenue in CMC Biosafety Testing Business (2019-2024)
11.1.5 WuXi Biologics Recent Development
11.2 Wuhan Canvest Biotechnology
11.2.1 Wuhan Canvest Biotechnology Company Details
11.2.2 Wuhan Canvest Biotechnology Business Overview
11.2.3 Wuhan Canvest Biotechnology CMC Biosafety Testing Introduction
11.2.4 Wuhan Canvest Biotechnology Revenue in CMC Biosafety Testing Business (2019-2024)
11.2.5 Wuhan Canvest Biotechnology Recent Development
11.3 Centre Testing International (CTI)
11.3.1 Centre Testing International (CTI) Company Details
11.3.2 Centre Testing International (CTI) Business Overview
11.3.3 Centre Testing International (CTI) CMC Biosafety Testing Introduction
11.3.4 Centre Testing International (CTI) Revenue in CMC Biosafety Testing Business (2019-2024)
11.3.5 Centre Testing International (CTI) Recent Development
11.4 Suzhou Liangchen Biotechnology
11.4.1 Suzhou Liangchen Biotechnology Company Details
11.4.2 Suzhou Liangchen Biotechnology Business Overview
11.4.3 Suzhou Liangchen Biotechnology CMC Biosafety Testing Introduction
11.4.4 Suzhou Liangchen Biotechnology Revenue in CMC Biosafety Testing Business (2019-2024)
11.4.5 Suzhou Liangchen Biotechnology Recent Development
11.5 JADE Biomedical
11.5.1 JADE Biomedical Company Details
11.5.2 JADE Biomedical Business Overview
11.5.3 JADE Biomedical CMC Biosafety Testing Introduction
11.5.4 JADE Biomedical Revenue in CMC Biosafety Testing Business (2019-2024)
11.5.5 JADE Biomedical Recent Development
11.6 Standard Testing Group
11.6.1 Standard Testing Group Company Details
11.6.2 Standard Testing Group Business Overview
11.6.3 Standard Testing Group CMC Biosafety Testing Introduction
11.6.4 Standard Testing Group Revenue in CMC Biosafety Testing Business (2019-2024)
11.6.5 Standard Testing Group Recent Development
11.7 Sino Tech World Biologicals
11.7.1 Sino Tech World Biologicals Company Details
11.7.2 Sino Tech World Biologicals Business Overview
11.7.3 Sino Tech World Biologicals CMC Biosafety Testing Introduction
11.7.4 Sino Tech World Biologicals Revenue in CMC Biosafety Testing Business (2019-2024)
11.7.5 Sino Tech World Biologicals Recent Development
11.8 Q2 Solutions
11.8.1 Q2 Solutions Company Details
11.8.2 Q2 Solutions Business Overview
11.8.3 Q2 Solutions CMC Biosafety Testing Introduction
11.8.4 Q2 Solutions Revenue in CMC Biosafety Testing Business (2019-2024)
11.8.5 Q2 Solutions Recent Development
11.9 Merck
11.9.1 Merck Company Details
11.9.2 Merck Business Overview
11.9.3 Merck CMC Biosafety Testing Introduction
11.9.4 Merck Revenue in CMC Biosafety Testing Business (2019-2024)
11.9.5 Merck Recent Development
11.10 Charles River Laboratories
11.10.1 Charles River Laboratories Company Details
11.10.2 Charles River Laboratories Business Overview
11.10.3 Charles River Laboratories CMC Biosafety Testing Introduction
11.10.4 Charles River Laboratories Revenue in CMC Biosafety Testing Business (2019-2024)
11.10.5 Charles River Laboratories Recent Development
11.11 Sartorius
11.11.1 Sartorius Company Details
11.11.2 Sartorius Business Overview
11.11.3 Sartorius CMC Biosafety Testing Introduction
11.11.4 Sartorius Revenue in CMC Biosafety Testing Business (2019-2024)
11.11.5 Sartorius Recent Development
11.12 Eurofins Scientific
11.12.1 Eurofins Scientific Company Details
11.12.2 Eurofins Scientific Business Overview
11.12.3 Eurofins Scientific CMC Biosafety Testing Introduction
11.12.4 Eurofins Scientific Revenue in CMC Biosafety Testing Business (2019-2024)
11.12.5 Eurofins Scientific Recent Development
11.13 CAS Testing Technical Services
11.13.1 CAS Testing Technical Services Company Details
11.13.2 CAS Testing Technical Services Business Overview
11.13.3 CAS Testing Technical Services CMC Biosafety Testing Introduction
11.13.4 CAS Testing Technical Services Revenue in CMC Biosafety Testing Business (2019-2024)
11.13.5 CAS Testing Technical Services Recent Development
11.14 SGS
11.14.1 SGS Company Details
11.14.2 SGS Business Overview
11.14.3 SGS CMC Biosafety Testing Introduction
11.14.4 SGS Revenue in CMC Biosafety Testing Business (2019-2024)
11.14.5 SGS Recent Development
11.15 Samsung Biologics
11.15.1 Samsung Biologics Company Details
11.15.2 Samsung Biologics Business Overview
11.15.3 Samsung Biologics CMC Biosafety Testing Introduction
11.15.4 Samsung Biologics Revenue in CMC Biosafety Testing Business (2019-2024)
11.15.5 Samsung Biologics Recent Development
11.16 NTEK
11.16.1 NTEK Company Details
11.16.2 NTEK Business Overview
11.16.3 NTEK CMC Biosafety Testing Introduction
11.16.4 NTEK Revenue in CMC Biosafety Testing Business (2019-2024)
11.16.5 NTEK Recent Development
11.17 Texcell
11.17.1 Texcell Company Details
11.17.2 Texcell Business Overview
11.17.3 Texcell CMC Biosafety Testing Introduction
11.17.4 Texcell Revenue in CMC Biosafety Testing Business (2019-2024)
11.17.5 Texcell Recent Development
11.18 Sino Biological
11.18.1 Sino Biological Company Details
11.18.2 Sino Biological Business Overview
11.18.3 Sino Biological CMC Biosafety Testing Introduction
11.18.4 Sino Biological Revenue in CMC Biosafety Testing Business (2019-2024)
11.18.5 Sino Biological Recent Development
11.19 Miracle Points
11.19.1 Miracle Points Company Details
11.19.2 Miracle Points Business Overview
11.19.3 Miracle Points CMC Biosafety Testing Introduction
11.19.4 Miracle Points Revenue in CMC Biosafety Testing Business (2019-2024)
11.19.5 Miracle Points Recent Development
11.20 Suzhou Cefety Bioscience
11.20.1 Suzhou Cefety Bioscience Company Details
11.20.2 Suzhou Cefety Bioscience Business Overview
11.20.3 Suzhou Cefety Bioscience CMC Biosafety Testing Introduction
11.20.4 Suzhou Cefety Bioscience Revenue in CMC Biosafety Testing Business (2019-2024)
11.20.5 Suzhou Cefety Bioscience Recent Development
11.21 Zhejiang Hengyu Biological
11.21.1 Zhejiang Hengyu Biological Company Details
11.21.2 Zhejiang Hengyu Biological Business Overview
11.21.3 Zhejiang Hengyu Biological CMC Biosafety Testing Introduction
11.21.4 Zhejiang Hengyu Biological Revenue in CMC Biosafety Testing Business (2019-2024)
11.21.5 Zhejiang Hengyu Biological Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 麻豆原创 Size Estimation
13.1.1.3 麻豆原创 Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
WuXi Biologics
Wuhan Canvest Biotechnology
Centre Testing International (CTI)
Suzhou Liangchen Biotechnology
JADE Biomedical
Standard Testing Group
Sino Tech World Biologicals
Q2 Solutions
Merck
Charles River Laboratories
Sartorius
Eurofins Scientific
CAS Testing Technical Services
SGS
Samsung Biologics
NTEK
Texcell
Sino Biological
Miracle Points
Suzhou Cefety Bioscience
Zhejiang Hengyu Biological
听
听
*If Applicable.
